Advertisement

Acorda Therapeutics, Inc. ACOR

Set alert

Price alert · ACOR

All alert types
0.66 +0.66 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
821.03K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.69
Beta
1.46
Short ratio
1.84
Inst. own
13.22%
Dividend
0.00
Ex-div date
Earnings
May 9, 2024
50-d avg
9.33
200-d avg
12.55
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ACOR has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $16.58MGross Profit → Expenses: $16.58MRevenue → Cost of Revenue: $3.71MExpenses → Selling, General & Admin: $28.37MExpenses → Research & Development: $954.00KExpenses → Other Operating Expenses: $644.00KExpenses → Other Expenses: $13.89MExpenses → Income Tax: $114.00KNet Loss → Expenses: $27.39MGross Profit$16.58MNet Loss$27.39MCost of Revenue$3.71MExpenses$43.98MSelling, General & Admin$28.37MResearch & Development$954.00KOther Operating Expenses$644.00KOther Expenses$13.89MIncome Tax$114.00KRevenue$20.29M

Period ending Dec 31, 2023 · select a line to chart its history

Income statement

ACOR quarterly income statement
37.98M
37.98M
5.60M
32.39M
282.23M
1.01M
22.21M
-249.84M
8.21M
-38.11M
-217.76M
-217.76M
-217.76M
-217.76M
-175.32
-175.32
-175.32
-247.66M
-247.66M
1.24M
1.24M

Balance sheet

ACOR quarterly balance sheet
30.61M
30.61M
17.30M
74.79M
6.30M
108.53M
187.73M
190.90M
227.77M
3.17M
266.48M
-1.19B
1.43M
-157.96M
-157.96M
33.73M
190.90M
227.00K
22.99M
16.16M
38.71M
13.37M

Cash flow

ACOR quarterly cash flow
7.91M
-2.97M
-44.00K
-44.00K
-3.02M
93.00K
138.00K
Advertisement